Status:
COMPLETED
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
Lead Sponsor:
Fayoum University
Conditions:
Schizophrenia Spectrum and Other Psychotic Disorders
Periodontal Diseases
Eligibility:
All Genders
20+ years
Brief Summary
The aim of the present cohort retrospective study is to explore the effect of antipsychotics on periodontal health and the possible effect of antipsychotic-induced hyperprolactinemia as a risk factor ...
Detailed Description
Background and objective: The aim of the present cohort retrospective study is to explore the effect of antipsychotics on periodontal health and the possible effect of antipsychotic-induced hyperprola...
Eligibility Criteria
Inclusion
- with the diagnosis of schizophrenia
- over 20 years old
- did not receive any periodontal treatment for the past year
- with at least 20 remaining teeth.
Exclusion
- with systemic condition that may affect periodontal status such as; DM, cardiovascular diseases, metabolic syndrome, osteoporosis, AIDS and chronic alcoholism
- having local factors that may aggravate and predispose for periodontal diseases such as; orthodontic and prosthetic appliances, parafunctional habits, and heavy smoking
- receiving any systemic medication and/or systemic antibiotics for the past 6 months.
- patients undergoing any type of periodontal treatment for the past year and
- within childhood and adolescence psychiatry section.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT06040944
Start Date
September 1 2022
End Date
November 1 2022
Last Update
September 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rania Hassan Shalby
Giza, Egypt